Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 174Recruiting 53Active not recruiting 53Terminated 43Withdrawn 22Unknown 16Not yet recruiting 11Suspended 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1CNS 1

Conditions

Neoplasm Metastasis 1Meningioma 1

Interventions

Specimen Handling 29Magnetic Resonance Spectroscopy 18Biopsy 16Cyclophosphamide 15Nivolumab 10Paclitaxel 9Vincristine 8Cisplatin 8venetoclax 7Prednisone 7Gemcitabine 7Doxorubicin 7Bevacizumab 7Azacitidine 7pembrolizumab 6Radiotherapy 6Fluorouracil 6Etoposide 6Drug Therapy 6Docetaxel 6Rituximab 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Injections 5Everolimus 5Capecitabine 5fludarabine phosphate 4Taxes 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Interventional × Surveys and Questionnaires × Clear all
NCT07353229 2026-01-23

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Thomas Jefferson University

Phase 1 Suspended
24 enrolled
CNS

Meningioma

NCT05351294 2026-01-07

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

Rutgers, The State University of New Jersey

Phase 3 Suspended
156 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡